September 8：Based on the revision of rules detailing the scope of the medical expenses subsidy in the “Rare Disease and Orphan Drug Act” existing subsidy procedures and content were extended to provide individuals suffering from rare diseases with more comprehensive care. In concert, the “Regulations Governing Medical Subsidies for Rare Diseases” was renamed “Regulations Governing Medical Care Subsidies for Rare Diseases.”

• Facebook
• Line
• Twitter
• Plurk
• Email
• Print
• ShortUrl